Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

NPS-1034 shows promise in EGFR-mutant cancer models

July 16, 2012

New fusion protein from Bristol-Myers Squibb demonstrates antidiabetic activity

July 16, 2012

Lilly presents promising results for the gemcitabine prodrug LY-2334737

July 13, 2012

Clinical data updated for ibrutinib

July 13, 2012

Overall response rate over 80% seen in elotuzumab trial

July 13, 2012

Amgen presents clinical results for ganitumab

July 13, 2012

HM-781-36B proves safe and well tolerated in patients with cancer

July 13, 2012

F-14512 evaluated in phase I acute myeloid leukemia trial

July 13, 2012

Scientists in Taiwan discover new candidate marker of HCC prognosis

July 12, 2012

Human growth hormone analogue displays extended half-life in vivo

July 12, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...